| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 131.971.121 $ | 72,28 | 6.429.019 | |||||||
| APELLIS PHARMACEUTICALS INC | Apellis Pharmaceuticals, Inc. | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 2.461.791 $ | 1,35 | 60.117 | |
| REVOLUTION MEDICINES INC | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 2.174.338 $ | 1,19 | 15.087 | |
| TRAVERE THERAPEUTICS INC | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 2.138.727 $ | 1,17 | 50.777 | |
| ARROWHEAD PHARMACEUTICALS INC | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 1.900.193 $ | 1,04 | 25.860 | |
| TWIST BIOSCIENCE CORP | Twist Bioscience Corporation | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 1.874.082 $ | 1,03 | 32.063 | |
| SUMMIT THERAPEUTICS INC | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 1.852.019 $ | 1,01 | 86.301 | |
| ALKERMES PLC | Alkermes plc | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 1.823.880 $ | 1,00 | 54.105 | |
| TG THERAPEUTICS INC | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 1.809.426 $ | 0,99 | 53.565 | |
| MADRIGAL PHARMACEUTICALS INC | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 1.801.552 $ | 0,99 | 3.482 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 1.747.342 $ | 0,96 | 57.611 | |
| APOGEE THERAPEUTICS INC | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 1.667.664 $ | 0,91 | 20.119 | |
| SCHOLAR ROCK HOLDING CORP | Scholar Rock Holding Corporation | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 1.621.842 $ | 0,89 | 34.796 | |
| PRAXIS PRECISION MEDICINES INC | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 1.612.961 $ | 0,88 | 5.059 | |
| EXELIXIS INC | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 1.600.026 $ | 0,88 | 35.988 | |
| MIRUM PHARMACEUTICALS INC | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 1.593.549 $ | 0,87 | 16.376 | |
| UNITED THERAPEUTICS CORP | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.575.783 $ | 0,86 | 2.758 | |
| NATERA INC | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 1.575.475 $ | 0,86 | 7.642 | |
| CRISPR THERAPEUTICS AG | CRISPR Therapeutics A.G. | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 1.575.015 $ | 0,86 | 30.092 | |
| CELCUITY INC | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 1.575.002 $ | 0,86 | 12.979 | |
| KRYSTAL BIOTECH INC | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.545.236 $ | 0,85 | 5.892 | |
| PROTAGONIST THERAPEUTICS INC | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.541.260 $ | 0,84 | 15.573 | |
| NEUROCRINE BIOSCIENCES INC | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 1.527.240 $ | 0,84 | 11.599 | |
| INCYTE CORP | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.512.221 $ | 0,83 | 15.873 | |
| CG ONCOLOGY INC | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 1.511.327 $ | 0,83 | 22.645 | |
| CYTOKINETICS INC | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 1.510.524 $ | 0,83 | 23.613 | |
| NUVALENT INC | Nuvalent, Inc. | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 1.505.905 $ | 0,82 | 15.017 | |
| IONIS PHARMACEUTICALS INC | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.501.854 $ | 0,82 | 20.089 | |
| BRIDGEBIO PHARMA INC | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 1.496.581 $ | 0,82 | 21.046 | |
| VAXCYTE INC | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 1.494.937 $ | 0,82 | 26.117 | |
| KYMERA THERAPEUTICS INC | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 1.494.201 $ | 0,82 | 18.431 | |
| BIOGEN INC | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.493.041 $ | 0,82 | 7.888 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 1.490.403 $ | 0,82 | 41.643 | |
| PTC THERAPEUTICS INC | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 1.488.508 $ | 0,82 | 22.879 | |
| INSMED INC | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.469.365 $ | 0,80 | 10.778 | |
| ALNYLAM PHARMACEUTICALS INC | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 1.451.199 $ | 0,79 | 4.689 | |
| ROIVANT SCIENCES LTD | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.449.153 $ | 0,79 | 50.794 | |
| HALOZYME THERAPEUTICS INC | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 1.438.780 $ | 0,79 | 22.601 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 1.415.654 $ | 0,78 | 60.967 | |
| SPYRE THERAPEUTICS INC | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 1.411.646 $ | 0,77 | 18.961 | |
| SOLENO THERAPEUTICS INC | Soleno Therapeutics, Inc. | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 1.400.945 $ | 0,77 | 26.523 | |
| ABBVIE INC | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 1.394.501 $ | 0,76 | 6.599 | |
| AMGEN INC | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.377.729 $ | 0,75 | 3.979 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.371.696 $ | 0,75 | 1.940 | |
| ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 1.360.592 $ | 0,75 | 55.107 | |
| ACADIA PHARMACEUTICALS INC | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 1.358.629 $ | 0,74 | 60.518 | |
| RHYTHM PHARMACEUTICALS INC | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 1.357.980 $ | 0,74 | 16.691 | |
| GILEAD SCIENCES INC | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.346.474 $ | 0,74 | 10.291 | |
| BIOMARIN PHARMACEUTICAL INC | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 1.342.844 $ | 0,74 | 24.909 | |
| VIKING THERAPEUTICS INC | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 1.310.059 $ | 0,72 | 42.016 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 1.303.936 $ | 0,71 | 3.051 | |
| IMMUNITYBIO INC | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 1.289.928 $ | 0,71 | 181.680 | |
| IMMUNOVANT INC | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 1.235.369 $ | 0,68 | 45.510 | |
| MODERNA INC | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 1.233.259 $ | 0,68 | 26.845 | |
| VERA THERAPEUTICS INC | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 1.207.393 $ | 0,66 | 33.906 | |
| IMMUNOME INC | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 1.193.752 $ | 0,65 | 52.038 | |
| DISC MEDICINE INC | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 1.183.473 $ | 0,65 | 17.945 | |
| VERACYTE INC | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 1.142.785 $ | 0,63 | 34.714 | |
| SAREPTA THERAPEUTICS INC | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 1.131.654 $ | 0,62 | 54.198 | |
| CATALYST PHARMACEUTICALS INC | Catalyst Pharmaceuticals, Inc. | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 1.131.304 $ | 0,62 | 40.217 | |
| BIOCRYST PHARMACEUTICALS INC | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 1.080.953 $ | 0,59 | 118.008 | |
| DYNE THERAPEUTICS INC | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 1.069.690 $ | 0,59 | 60.951 | |
| KODIAK SCIENCES INC | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 1.035.650 $ | 0,57 | 23.819 | |
| RECURSION PHARMACEUTICALS INC | Recursion Pharmaceuticals, Inc. | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 1.026.468 $ | 0,56 | 296.667 | |
| GRAIL INC | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 1.005.810 $ | 0,55 | 18.462 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 977.976 $ | 0,54 | 38.352 | |
| AGIOS PHARMACEUTICALS INC | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 958.272 $ | 0,52 | 34.224 | |
| DENALI THERAPEUTICS INC | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 939.650 $ | 0,51 | 50.195 | |
| ORUKA THERAPEUTICS INC | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 922.577 $ | 0,51 | 13.486 | |
| DIANTHUS THERAPEUTICS INC | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 913.120 $ | 0,50 | 10.400 | |
| INTELLIA THERAPEUTICS INC | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 896.973 $ | 0,49 | 66.541 | |
| ERASCA INC | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 893.865 $ | 0,49 | 83.931 | |
| ADMA BIOLOGICS INC | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 893.544 $ | 0,49 | 87.175 | |
| SYNDAX PHARMACEUTICALS INC | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 890.352 $ | 0,49 | 41.547 | |
| ARDELYX INC | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 860.000 $ | 0,47 | 135.861 | |
| IDEAYA BIOSCIENCES INC | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 840.292 $ | 0,46 | 28.876 | |
| MINERALYS THERAPEUTICS INC | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 837.663 $ | 0,46 | 31.432 | |
| NURIX THERAPEUTICS INC | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 831.794 $ | 0,46 | 49.808 | |
| TANGO THERAPEUTICS INC | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 755.900 $ | 0,41 | 34.963 | |
| CELLDEX THERAPEUTICS INC | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 712.477 $ | 0,39 | 21.669 | |
| CAPRICOR THERAPEUTICS INC | Capricor Therapeutics, Inc. | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 697.490 $ | 0,38 | 20.771 | |
| VERICEL CORP | Vericel Corporation | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 687.133 $ | 0,38 | 19.785 | |
| INHIBRX BIOSCIENCES INC | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 678.482 $ | 0,37 | 5.251 | |
| MONTE ROSA THERAPEUTICS INC | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 667.378 $ | 0,37 | 34.850 | |
| NOVAVAX INC | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 655.786 $ | 0,36 | 82.749 | |
| BIOHAVEN LTD | Biohaven Ltd. | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 653.434 $ | 0,36 | 68.137 | |
| STOKE THERAPEUTICS INC | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 652.862 $ | 0,36 | 19.953 | |
| RELAY THERAPEUTICS INC | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 650.242 $ | 0,36 | 50.173 | |
| TAYSHA GENE THERAPIES INC | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 638.367 $ | 0,35 | 99.901 | |
| VIRIDIAN THERAPEUTICS INC | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 637.537 $ | 0,35 | 47.295 | |
| OLEMA PHARMACEUTICALS INC | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 631.317 $ | 0,35 | 43.811 | |
| PALVELLA THERAPEUTICS INC | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 623.635 $ | 0,34 | 4.860 | |
| UNIQURE NV | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 599.936 $ | 0,33 | 30.072 | |
| ANAPTYSBIO INC | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 596.565 $ | 0,33 | 9.076 | |
| CORVUS PHARMACEUTICALS INC | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 569.792 $ | 0,31 | 37.511 | |
| MANNKIND CORP | MannKind Corporation | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 548.211 $ | 0,30 | 193.714 | |
| CAREDX INC | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 545.784 $ | 0,30 | 26.227 | |
| KALVISTA PHARMACEUTICALS INC | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 508.833 $ | 0,28 | 19.086 | |
| IOVANCE BIOTHERAPEUTICS INC | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 484.636 $ | 0,27 | 144.237 | |
| VIR BIOTECHNOLOGY INC | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 457.366 $ | 0,25 | 44.774 | |
| GERON CORP | Geron Corporation | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 453.276 $ | 0,25 | 294.335 | |
| PRECIGEN INC | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 442.345 $ | 0,24 | 106.333 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS Life Sciences Group, Inc. | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 411.281 $ | 0,23 | 83.087 | |
| TYRA BIOSCIENCES INC | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 403.482 $ | 0,22 | 11.611 | |
| ABSCI CORP | Absci Corporation | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 399.323 $ | 0,22 | 80.266 | |
| ANNEXON INC | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 397.464 $ | 0,22 | 67.711 | |
| KURA ONCOLOGY INC | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 394.595 $ | 0,22 | 44.688 | |
| SANA BIOTECHNOLOGY INC | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 387.503 $ | 0,21 | 117.782 | |
| ARRIVENT BIOPHARMA INC | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 385.796 $ | 0,21 | 12.409 | |
| ORIC PHARMACEUTICALS INC | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 380.064 $ | 0,21 | 38.468 | |
| RIGEL PHARMACEUTICALS INC | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 362.724 $ | 0,20 | 12.551 | |
| JANUX THERAPEUTICS INC | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 362.512 $ | 0,20 | 25.227 | |
| CYTOMX THERAPEUTICS INC | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 337.127 $ | 0,18 | 79.888 | |
| SAVARA INC | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 329.821 $ | 0,18 | 62.943 | |
| ARS PHARMACEUTICALS INC | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 323.668 $ | 0,18 | 39.185 | |
| ZENAS BIOPHARMA INC | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 310.009 $ | 0,17 | 16.046 | |
| CULLINAN THERAPEUTICS INC | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 302.055 $ | 0,17 | 23.146 | |
| XENCOR INC | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 300.362 $ | 0,16 | 25.177 | |
| IRONWOOD PHARMACEUTICALS INC | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 297.656 $ | 0,16 | 72.159 | |
| SIONNA THERAPEUTICS INC | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 285.374 $ | 0,16 | 7.374 | |
| BICARA THERAPEUTICS INC | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 273.181 $ | 0,15 | 12.659 | |
| HYPERLIQUID STRATEGIES INC | Hyperliquid Strategies, Inc. | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 266.271 $ | 0,15 | 44.231 | |
| PRIME MEDICINE INC | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 254.577 $ | 0,14 | 71.813 | |
| VOR BIOPHARMA INC | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 241.088 $ | 0,13 | 16.824 | |
| EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 233.576 $ | 0,13 | 28.381 | |
| REGENXBIO INC | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 220.743 $ | 0,12 | 24.609 | |
| VANDA PHARMACEUTICALS INC | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 218.304 $ | 0,12 | 30.747 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 211.199 $ | 0,12 | 9.076 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 210.955 $ | 0,12 | 23.783 | |
| ALLOGENE THERAPEUTICS INC | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 200.333 $ | 0,11 | 94.053 | |
| ALTIMMUNE INC | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 200.301 $ | 0,11 | 77.039 | |
| VERASTEM INC | Verastem, Inc. | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 198.466 $ | 0,11 | 36.349 | |
| PROTHENA CORP PLC | Prothena Corp plc | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 196.249 $ | 0,11 | 17.744 | |
| LEXEO THERAPEUTICS INC | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 191.409 $ | 0,10 | 33.610 | |
| MYRIAD GENETICS INC | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 185.146 $ | 0,10 | 38.978 | |
| ARBUTUS BIOPHARMA CORP | Arbutus Biopharma Corporation | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 171.881 $ | 0,09 | 40.924 | |
| ROCKET PHARMACEUTICALS INC | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 163.696 $ | 0,09 | 47.039 | |
| OCUGEN INC | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 163.032 $ | 0,09 | 94.238 | |
| ANAVEX LIFE SCIENCES CORP | Anavex Life Sciences Corporation | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 159.936 $ | 0,09 | 47.885 | |
| AKEBIA THERAPEUTICS INC | Akebia Therapeutics, Inc. | EC | 00972D105 | Long | Börsenkurs (Stufe 1) | 150.370 $ | 0,08 | 108.964 | |
| INVIVYD INC | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 142.841 $ | 0,08 | 102.029 | |
| MIMEDX GROUP INC | MiMedx Group, Inc. | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 138.392 $ | 0,08 | 41.188 | |
| PERSPECTIVE THERAPEUTICS INC | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 120.576 $ | 0,07 | 30.917 | |
| COMPASS THERAPEUTICS INC | Compass Therapeutics, Inc. | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 115.485 $ | 0,06 | 65.246 | |
| REPLIMUNE GROUP INC | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 101.425 $ | 0,06 | 39.465 | |
| DAMORA THERAPEUTICS INC | Damora Therapeutics, Inc. | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 43.442 $ | 0,02 | 1.693 | |
| 131.971.121 $ | 72,28 | 6.429.019 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.